Four pegylated drugs approved by FDA in the last five years

Creative PEGWorks

  • Plegridy (Biogen 2014) — PEGylated Interferon Beta-1a for the treatment of patients with relapsing forms of multiple sclerosis.
  • Naloxegol (Movantik) (AstraZeneca 2014) — PEGylated naloxol for the treatment of opioid-induced constipation in adults patients with chronic non-cancer pain.
  • Pegnesatide (Omontys) (Takeda Pharmaceuticals, 2012) — To treat anemia associated with chronic kidney disease in adult patients on dialysis.
  • Pegloticase (Krystexxa) (Savient 2010) — PEGylated uricase for the treatment of gout.

View original post

This entry was posted in Blogs. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s